🏅 Gate2Brain was one of the awarded companies within the 𝘽𝙐𝙎𝙄𝙉𝙀𝙎𝙎 𝙏𝙍𝘼𝙉𝙎𝙁𝙊𝙍𝙈𝘼𝙏𝙄𝙊𝙉 category: a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier.

"At G2B we had a dream, to cross barriers and bring medicines beyond them. G2B has developed a peptide-based patented technology that help drugs from different natures to cross the Blood Brain Barrier (BBB) and reach the brain. 1/4 of us will suffer from a Central Nervous System disease during our life. There are promising drug candidates for most diseases but 98% of them fail crossing the BBB. 𝐆𝟐𝐁-𝟎𝟎𝟐 is a therapeutic opportunity to fight against pediatric brain tumors. We have achieved promising evidence on the therapeutic efficacy of 𝐆𝟐𝐁-𝟎𝟎𝟐 in orthotopic patient derived animal models of brain tumors in terms of tumor reduction and increase survival."

We would like to express our gratitude to Gate2Brain for their valuable testimonial. 🙏 Congratulations for your achievements! 🎉